BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 9512698)

  • 21. Zinostatin stimalamer-transcatheter arterial embolization for hepatocellular carcinoma: a comparison with lipiodol-transcatheter arterial embolization.
    Hirashima N; Sakakibara K; Itazu I; Hirai T; Nemoto A; Matsuura H; Kumada K; Nojiri O; Kano H
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-91-S6-96. PubMed ID: 9151922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A successful treatment using SMANCS-TAE for hepatocellular carcinoma with tumor thrombus in the portal trunk].
    Fukushima M; Fukutomi T; Tanabe Y; Hiroshige K; Yoshida K
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):1073-6. PubMed ID: 8687225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of transcatheter hepatic segmental or subsegmental infusion of SMANCS for treatment of hepatocellular carcinoma].
    Inoue Y; Tomoda K; Oi H; Nakamura H
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():56-63. PubMed ID: 9512689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
    Takizawa K; Obuchi M; Honda M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
    Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathologic study of hepatocellular carcinoma treated by TAI and TAE with SMANCS].
    Takayasu K; Iwata R; Furukawa T; Nakanishi Y; Sakamoto M
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():70-2. PubMed ID: 9512691
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results of SMANCS/Lipiodol injection therapy for multiple intrahepatic recurrence of hepatocellular carcinoma].
    Nakaba H; Hashimoto T; Sunada S; Akamatsu D; Ito A; Teramoto S; Ohara S; Katayama S
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():46-50. PubMed ID: 9512687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol].
    Konno T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):373-80. PubMed ID: 3028275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
    Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of hepatocellular carcinoma with tumor thrombus in the right atrium successfully treated by arterial administration of lipiodol-SMANCS].
    Yamada K; Sato T; Yamada A; Tanaka S; Fujii S; Matuo R; Murata K; Manabe T; Oda J
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):361-4. PubMed ID: 10065101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Two cases of long-term survival with hepatocellular carcinoma following targeting therapy with SMANCS/lipiodol].
    Inoue Y; Nakamura H
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):99-101. PubMed ID: 8546478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of long-term survival with TAE resistant multiple recurrence HCC successfully treated by hepatic resection].
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Hiramatsu N; Hayashi N; Monden M
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1717-21. PubMed ID: 14619502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intra-arterial infusion of SMANCS for treatment of patients with hepatocellular carcinoma--adverse reactions and complications].
    Sakaguchi T; Yoshimatsu S; Sagara K; Yamashita Y; Takahashi M
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():64-9. PubMed ID: 9512690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of recurrent multiple HCC after surgical resection showing regression by two TAEs using 5-FU and zinostatin stimalamer].
    Takiya S; Sawada T; Takahashi K; Tagaya T; Fukuzawa Y; Kato K; Murata K; Ikeda H
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1205-8. PubMed ID: 8751812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Arterial infusion chemotherapy with SMANCS].
    Nekohashi T; Maruno J; Sanjou A; Toda G
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():629-33. PubMed ID: 11762025
    [No Abstract]   [Full Text] [Related]  

  • 36. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
    Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of massive hepatoma which responded to SMANCS/Lipiodol regimen with intra-arterial infusion].
    Kubo M; Fuchigami T; Murata S; Konno T; Maeda H
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2953-6. PubMed ID: 2551233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Transcatheter arterial embolization for advanced hepatocellular carcinoma--indications and limitations].
    Nakamura H; Kawata S; Takamura M; Osuga K; Murakami T
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1509-15. PubMed ID: 11015994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Arterial administration of oily anticancer agents dissolved in lipiodol fluid in recurrence of hepatoma after hepatic resection and in metastatic liver cancer].
    Ohtsuka N; Konno T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1351-8. PubMed ID: 2837992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advantages and disadvantages of SMANCS-Lipiodol intrahepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma].
    Suzuki M; Fukuhara K; Unno M; Endoh K; Takeuchi H; Kodama H; Oikawa M; Matsuno S
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():39-45. PubMed ID: 9512686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.